BioVentureHub + IBM SwedenBy Jamie Smith - 19 Feb 2020
AstraZeneca announced today that it has established a new collaboration with IBM Sweden through the BioVentureHub. From now on, small and medium-sized enterprises (SMEs) connected to IBM Sweden or AstraZeneca’s BioVentureHub will be offered access to the other partner’s open innovation platform. The collaboration aims to stimulate growth of SMEs, support knowledge exchange between the life science and digital technology industries, and strengthen digital health expertise.
“We are seeing more and more life science companies going digital and digital companies going life science; and there is often a lack of complementary skills and know-how. Our exciting collaboration with IBM will provide SMEs and research groups with a unique, non-competitive, collaboration environment that can contribute with both pockets of expertise and foster breakthrough digital health solutions. Besides supporting growth strategies for Swedish SMEs, we also hope the collaboration will help attract international digital health companies to Sweden,” says Magnus Björsne, CEO, AstraZeneca BioVentureHub.
Click here to see the full press release (in Swedish) - PDF versions in SWE and ENG below.